Medindia

X

Why Promising Dementia Drugs Failed in Clinical Trials Explained

by Kathy Jones on  December 8, 2013 at 7:44 PM Research News   - G J E 4
The most common cause of dementia among older people, Alzheimer's disease, currently has no effective drugs to stop, slow or prevent disease progression.
 Why Promising Dementia Drugs Failed in Clinical Trials Explained
Why Promising Dementia Drugs Failed in Clinical Trials Explained
Advertisement

A study online December 5th in the ISSCR's journal Stem Cell Reports, published by Cell Press, provide interesting clues on why non-steroidal anti-inflammatory drugs (NSAIDs), which have successfully treated molecular signs of Alzheimer's disease in cell and animal models, eventually failed in clinical studies. Whereas the compounds worked in non-neuronal cells lines typically used in pharmaceutical drug screening, the authors found that human neurons are resistant to this class of drugs. "The results of our study are significant for future drug development approaches, because they imply that compound screening and validation studies might be much more reliable if they are conducted using the human cell type affected by the disease in question," says Oliver Brüstle of the University of Bonn who senior-authored the study together with his colleague Philipp Koch.

Advertisement


Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All